Inhibition of dengue virus replication by novel inhibitors of RNA-dependent RNA polymerase and protease activities

References

• Rothman AL. Immunity to dengue virus: a tale of original antigenic sin and tropical cytokine storms. Nat Rev Immunol 2011;11:532–43.
   PubMed Web of Science ®Google Scholar
• Halstead SH. Dengue virus-mosquito interactions. Annu Rev Entomol 2008;53:273–91.
   PubMed Web of Science ®Google Scholar
• Wilder-Smith A, Ooi EE, Vasudevan SG, Gubler DJ. Update on dengue: epidemiology, virus evolution, antiviral drugs, and vaccine development. Curr Infect Dis Rep 2010;12:157–64.
   PubMedGoogle Scholar
• Roche C, Cassar O, Laille M, Murgue B. Dengue-3 virus genomic differences that correlate with in vitro phenotype on a human cell line but not with disease severity. Microbes Infect 2007;9:63–9.
   PubMed Web of Science ®Google Scholar
• Shurtleff AC, Beasley DW, Chen JJ, et al. Genetic variation in the 3' non-coding region of dengue viruses. Virology 2001;281:75–87.
   PubMed Web of Science ®Google Scholar
• Silva RLA, de Silva AM, Harris E, MacDonald GH. Genetic analysis of dengue 3 virus subtype III 5′ and 3′ non-coding regions. Virus Res 2008;135:320–5.
   PubMed Web of Science ®Google Scholar
• Vasilakis N, Weaver SC. The history and evolution of human dengue emergence. Adv Virus Res 2008;72:1–76.
   PubMed Web of Science ®Google Scholar
• Zhou Y, Mammen MP, Klungthong C, et al. Comparative analysis reveals no consistent association between the secondary structure of the 3’-untranslated region of dengue viruses and disease syndrome. J Gen Virol 2006;87:2595–603.
   PubMed Web of Science ®Google Scholar
• Dejnirattisai W, Jumnainsong A, Onsirisakul N, et al. Cross-reacting antibodies enhance dengue virus infection in humans. Science 2010;328:745–8.
   PubMed Web of Science ®Google Scholar
• Beltramello M, Williams KL, Simmons CP, et al. The human immune response to dengue virus is dominated by highly cross-reactive antibodies endowed with neutralizing and enhancing activity. Cell Host Microbe 2010;8:271–83.
   PubMed Web of Science ®Google Scholar
• de Alwis R, Beltramello M, Messer WB, et al. In-depth analysis of the antibody response of individuals exposed to primary dengue virus infection. PLoS Negl Trop Dis 2011;6:e1188.
   Web of Science ®Google Scholar
• Smith SA, de Alwis AR, Kose N, et al. Isolation of dengue virus-specific memory B cells with live virus antigen from human subjects following natural infection reveals the presence of diverse novel functional groups of antibody clones. J Virol 2014;88:12233–41.
   PubMed Web of Science ®Google Scholar
• Yotmanee P, Rungrotmongkol T, Wichapong K, et al. Binding specificity of polypeptide substrates in NS2B/NS3pro serine protease of dengue virus type 2: a molecular dynamics study. J Mol Graph Model 2015;60:24–33.
   PubMed Web of Science ®Google Scholar
• Khromykh AA, Kenney MT, Westaway EG. Trans-complementation of flavivirus RNA polymerase gene NS5 by using Kunjin virus replicon-expressing BHK cells. J Virol 1988;72:7270–9.
   Web of Science ®Google Scholar
• Rawlinson SM, Pryor MJ, Wright PJ, Jans DA. Dengue virus RNA polymerase NS5: a potential therapeutic target? Curr Drug Targets 2006;7:1623–38.
   PubMed Web of Science ®Google Scholar
• Tatem AJ, Hay SI, Rogers DJ. Global traffic and disease vector dispersal. Proc Natl Acad Sci USA 2006;103:6242–7.
   PubMed Web of Science ®Google Scholar
• Halstead SB. Licensed Dengue vaccine: public health conundrum and scientific challenge. Am J Trop Med Hyg 2016;95:741–5.
   Google Scholar
• Guy E, Lang J, Saville M, Jackson N. Vaccination against Dengue: challenges and current developments. Ann Rev Med 2016;67:387–404.
   PubMed Web of Science ®Google Scholar
• Noble CG, Chen YG, Dong H, et al. Strategies for development of dengue virus inhibitors. Antivir Res 2010;8:5450–62.
   Google Scholar
• Lim SP, Christian G, Noble CG, Shi PY. The dengue virus NS5 protein as a target for drug discovery. Antiviral Res 2015;119:57–67.
   PubMed Web of Science ®Google Scholar
• Tomlinsona SM, Malmstroma RD, Russoa A, et al. Structure-based discovery of dengue virus protease inhibitors. Antiviral Res 2009;82:110–14.
   PubMed Web of Science ®Google Scholar
• Silvestri R, Cascio MG, La Regina G, et al. Synthesis, cannabinoid receptor affinity and molecular modeling studies of substituted 1-aryl-5-(1H-pyrrol-1-yl)-1H-pyrazole-3-carboxamides. J Med Chem 2008;51:1560–76.
   PubMed Web of Science ®Google Scholar
• La Pietra V, La Regina G, Coluccia A, et al. Design, synthesis, and biological evaluatio of 1-phenylpyrazolo[3,4-e]pyrrolo[3,4-g]indolizine-4,6(1H,5H)-diones as new glycogen synthase kinase-3β inhibitors. J Med Chem 2013;56:10066–78.
   PubMed Web of Science ®Google Scholar
• Manvar D, Pelliccia S, La Regina G, et al. New 1-phenyl-5-(1H-pyrrol-1-yl)-1H-pyrazole-3-carboxamides inhibit hepatitis C virus replication via suppression of cyclooxygenase-2. Eur J Med Chem 2015;90:497–506.
   PubMed Web of Science ®Google Scholar
• Khan MF, Alam MM, Verma G, et al. The therapeutic voyage of pyrazole and its analogs: a review. Eur J Med Chem 2016;120:170–201.
   PubMed Web of Science ®Google Scholar
• Corelli F, Massa S, Stefancich G, et al. Agenti antiinfiammatori non steroidei. Nota V. - Sntesi di acidi 1-aril-5-(1-pirril)pirazolil-4-acetici a potenziale attività antiinfiammatoria. Farmaco 1988;43:251–65.
   Google Scholar
• Erbel P, Schiering N, D'Arcy A, et al. Structural basis for the activation of flaviviral NS3 proteases from dengue and West Nile virus. Nat Struct Mol Biol 2006;13:372–3.
   PubMed Web of Science ®Google Scholar
• Lipinski CA, Lombardo F, Dominy BW, Feeney PJ. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev 2001;46:3–26.
   PubMed Web of Science ®Google Scholar
• Korb O, Stutzle T, Exner TE, PLANTS: Application of ant colony optimization to structure-based drug design. In: Dorigo M, Gambardella LM, Birattari M, Martinoli A, Poli R, Stutzle T, eds. Ant colony optimization and swarm intelligence. Proceedings of the 5th International Workshop, ANTS, Lecture Notes in Computer Science, Series 4150, Berlin: Springer; 2006:47–258.
   Google Scholar
• Timiri AK, Sinha BN, Jayaprakash V. Progress and prospects on DENV protease inhibitors. Eur J Med Chem 2016;117:125–43.
   PubMed Web of Science ®Google Scholar
• PyMOL, v1.8.6.0, release March 9, 2017. Available from: https://www.pymol.org.
   Google Scholar
• Lin YT, Wu YH, Tseng CK, et al. Green tea phenolic epicatechins inhibit hepatitis C virus replication via cycloxygenase-2 and attenuate virus-induced inflammation. PLoS One 2013;8:e54466.
   PubMed Web of Science ®Google Scholar
• Lee JC, Tseng CK, Wu YH, et al. Characterization of the activity of 2'-C-methylcytidine against dengue virus replication. Antiviral Res 2015;116:1–9.
   PubMed Web of Science ®Google Scholar
• Wu SF, Lin CK, Chuang YS, et al. Anti-hepatitis C virus activity of 3-hydroxy caruilignan C from Swietenia macrophylla stems. J Viral Hepat 2012;19:364–70.
   PubMed Web of Science ®Google Scholar
• Mayani M, Filipe CDM, Ghosh R. Cascade ultrafiltration systems integrated processes for purification and concentration of lysozyme. J Membrane Sci 2010;347:150–8.
   Web of Science ®Google Scholar
• Hartwig S, Raschke S, Knebel B, et al. Secretome profiling of primary human skeletal muscle cells. Biochim Biophys Acta 2014;1844:1011–17.
   PubMed Web of Science ®Google Scholar
• Chao WW, Hong YH, Chen ML, Lin BF. Inhibitory effects of Angelica sinensis ethyl acetate extract and major compounds on NF-κB trans-activation activity and LPS-induced inflammation. J Ethnopharmacol 2010;129:244–9.
   PubMed Web of Science ®Google Scholar
• Hu G, Lou Z, Gupta M. The long non-coding RNA GAS5 cooperates with the eukaryotic translation initiation factor 4E to regulate c-Myc translation. PLoS One 2014;9:e107016.
   PubMed Web of Science ®Google Scholar
• Tseng CK, Lin CK, Wu YH, et al. Human heme oxygenase 1 is a potential host cell factor against dengue virus replication. Sci Rep 2016;6:32176.
   PubMed Web of Science ®Google Scholar
• Tannous BA. Gaussia luciferase reporter assay for monitoring biological processes in culture and in vivo. Nat Protoc 2009;4:582–91.
   PubMed Web of Science ®Google Scholar
• Tomlinson SM, Watowich SJ. Anthracene-based inhibitors of dengue virus NS2B-NS3 protease. Antiviral Res 2011;89:127–35.
   PubMed Web of Science ®Google Scholar
• 7-Amino-4-methylcoumarin (AMC) fluorophore-linked peptide substrate Boc-GRR-AMC. Bachem, CA, USA; 2016. Available from: http://www.bachem.com/ [last accessed 29 Nov 2016].
   Google Scholar
• Yildiz M, Ghosh S, Bell AJ, et al. Allosteric inhibition of the NS2B-NS3 protease from dengue virus. ACS Chem Biol 2013;8:2744–52.
   PubMed Web of Science ®Google Scholar
• Mukhametov A, Newhouse EI, Ab Aziz N, et al. Allosteric pocket of the dengue virus (serotype 2) NS2B/NS3 protease: in-silico ligand screening and molecular dynamics studies of inhibitors. J Mol Graph Model 2014;52:103–13.
   PubMed Web of Science ®Google Scholar
• Chandramouli S, Joseph JS, Daudenarde S, et al. Serotype-specific structural differences in the protease-cofactor complexes of the dengue virus family. J Virol 2010;84:3059–67.
   PubMed Web of Science ®Google Scholar
• Protein data bank. Available from: http://www.rcsb.org/pdb/home/home.do [last accessed 6 Dec 2016].
   Google Scholar